Oth hemorrhagic disord d/t intrns circ anticoag,antib,inhib

This code signifies a bleeding disorder caused by the body's immune system producing antibodies or inhibitors that interfere with normal blood clotting factors. These intrinsic circulating anticoagulants lead to an increased tendency for hemorrhage. It encompasses various acquired coagulopathies not specified elsewhere.

Apply this code when documentation indicates an acquired bleeding diathesis due to an intrinsic circulating anticoagulant, antibody, or inhibitor. This includes conditions like acquired hemophilia (e.g., factor VIII inhibitor) or other acquired factor deficiencies caused by autoantibodies. Supporting documentation should clearly identify the presence of such an inhibitor and its causal link to the hemorrhagic disorder.

• Ensure documentation specifies an acquired circulating anticoagulant, antibody, or inhibitor, not a congenital one.
• Distinguish from D68.311 (hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors with abnormal coagulation profile) if the coagulation profile is explicitly normal.
• Code any underlying condition causing the inhibitor (e.g., autoimmune disease, malignancy) as a primary diagnosis if applicable, with this code as a secondary diagnosis.